Järnerot G
Department of Medicine, Orebro Medical Center Hospital, Sweden.
Scand J Gastroenterol Suppl. 1988;148:21-3. doi: 10.3109/00365528809101542.
Experience of 804 patients treated with olsalazine has shown that this new 5-ASA based drug has a safe clinical profile and good tolerance. The only common side-effect was loose stools or overt diarrhoea, which necessitated withdrawal of the drug in 6.3% of the patients.